- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
Détention brevets de la classe A61K 31/137
Brevets de cette classe: 4650
Historique des publications depuis 10 ans
|
399
|
375
|
371
|
401
|
404
|
429
|
411
|
372
|
350
|
207
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Antecip Bioventures II LLC | 339 |
190 |
| Novartis AG | 10730 |
56 |
| The Regents of the University of California | 20059 |
51 |
| Grünenthal GmbH | 565 |
42 |
| Zogenix International Limited | 76 |
42 |
| Nalpropion Pharmaceuticals LLC | 73 |
39 |
| The Procter & Gamble Company | 22000 |
38 |
| Axsome Therapeutics, Inc. | 262 |
33 |
| Noven Pharmaceuticals, Inc. | 103 |
30 |
| Nevakar Injectables Inc. | 43 |
29 |
| Gruenenthal GmbH | 107 |
27 |
| Aquestive Therapeutics, Inc. | 182 |
25 |
| Pharnext | 91 |
23 |
| The Trustees of Columbia University in the City of New York | 3584 |
22 |
| Radius Pharmaceuticals, Inc. | 50 |
22 |
| Duke University | 3087 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
20 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2886 |
19 |
| Ironshore Pharmaceuticals & Development, Inc. | 36 |
19 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 217 |
18 |
| Autres propriétaires | 3885 |